All Stories

  1. Disease-modifying therapies for tauopathies: agents in the pipeline

    Article • Expert Review of Neurotherapeutics, April 2019, Taylor & Francis

    Professor Francesco Panza, Madia Lozupone, Professor GIANCARLO G LOGROSCINO, Dr Bruno P Imbimbo, Francesco Panza

  2. Promising therapies for the treatment of frontotemporal dementia clinical phenotypes: from symptomatic to disease-modifying drugs

    Article • Expert Opinion on Pharmacotherapy, April 2019, Taylor & Francis

    Professor GIANCARLO G LOGROSCINO, Madia Lozupone, Vittorio Dibello, Dr Bruno P Imbimbo, Dr Vittorio Dibello

  3. Amyotrophic lateral sclerosis mortality rates among ethnic groups in a predominant admixed population in Latin America: a population-based study in Ecuador

    Article • Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, April 2019, Taylor & Francis

    Professor GIANCARLO G LOGROSCINO

  4. Early pathological gambling in co-occurrence with semantic variant primary progressive aphasia: a case report

    Article • Clinical Interventions in Aging, April 2019, Dove Medical Press

    Professor GIANCARLO G LOGROSCINO, Francesco Giaquinto

  5. BACE inhibitors in clinical development for the treatment of Alzheimer’s disease

    Article • Expert Review of Neurotherapeutics, October 2018, Taylor & Francis

    Madia Lozupone, Vittorio Dibello, Professor GIANCARLO G LOGROSCINO, Dr Vittorio Dibello, Dr Bruno P Imbimbo, Francesco Panza

  6. Cardiovascular diseases may play a negative role in the prognosis of amyotrophic lateral sclerosis

    Article • European Journal of Neurology, April 2018, Wiley

    Professor GIANCARLO G LOGROSCINO

  7. Trauma and amyotrophic lateral sclerosis: a european population-based case-control study from the EURALS consortium

    Article • Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, October 2017, Taylor & Francis

    Professor GIANCARLO G LOGROSCINO, MD MARIA SOFIA COTELLI, MD Marco Poloni

  8. Midlife Metabolic Profile and the Risk of Late-Life Cognitive Decline

    Article • Journal of Alzheimer s Disease, July 2017, IOS Press

    Professor GIANCARLO G LOGROSCINO, Francesco Panza, Madia Lozupone, Dr Bruno P Imbimbo

  9. Time to generalization and prediction of survival in patients with amyotrophic lateral sclerosis: a retrospective observational study

    Article • European Journal of Neurology, March 2016, Wiley

    Professor GIANCARLO G LOGROSCINO, Francesco Panza

  10. I Need to Freeze My Gait

    Article • Movement Disorders Clinical Practice, July 2015, Wiley

    Professor GIANCARLO G LOGROSCINO

  11. A community study outlines how to prevent Parkinson's disease motor complications in the clinic

    Article • European Journal of Neurology, July 2015, Wiley

    Professor GIANCARLO G LOGROSCINO

  12. Cerebrospinal fluid neurofilament light chain levels: marker of progression to generalized amyotrophic lateral sclerosis

    Article • European Journal of Neurology, April 2014, Wiley

    Professor GIANCARLO G LOGROSCINO

  13. Elevated cerebrospinal fluid neurofilament light levels in patients with amyotrophic lateral sclerosis: a possible marker of disease severity and progression

    Article • European Journal of Neurology, June 2012, Wiley

    Professor GIANCARLO G LOGROSCINO